Ameritas Investment Partners, Inc. Passage Bio, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $4,740 - $10,061	-2,908 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$12.44 - $19.45 $10,238 - $16,007	823 Added 39.47%	2,908 $39,000
Q4 2020 Feb 12, 2021	BUY	$14.28 - $29.73 $12,637 - $26,311	885 Added 73.75%	2,085 $53,000
Q2 2020 Aug 05, 2020	BUY	$14.59 - $36.07 $17,508 - $43,284	1,200 New	1,200 $33,000

33M

20.3K

500

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $43M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.